Cargando…

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

BACKGROUND: The epithelial to mesenchymal transition (EMT) is a molecular process through which an epithelial cell undergoes transdifferentiation into a mesenchymal phenotype. The role of EMT in embryogenesis is well-characterized and increasing evidence suggests that elements of the transition may...

Descripción completa

Detalles Bibliográficos
Autores principales: Haslehurst, Alexandria M, Koti, Madhuri, Dharsee, Moyez, Nuin, Paulo, Evans, Ken, Geraci, Joseph, Childs, Timothy, Chen, Jian, Li, Jieran, Weberpals, Johanne, Davey, Scott, Squire, Jeremy, Park, Paul C, Feilotter, Harriet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342883/
https://www.ncbi.nlm.nih.gov/pubmed/22429801
http://dx.doi.org/10.1186/1471-2407-12-91
_version_ 1782231742622466048
author Haslehurst, Alexandria M
Koti, Madhuri
Dharsee, Moyez
Nuin, Paulo
Evans, Ken
Geraci, Joseph
Childs, Timothy
Chen, Jian
Li, Jieran
Weberpals, Johanne
Davey, Scott
Squire, Jeremy
Park, Paul C
Feilotter, Harriet
author_facet Haslehurst, Alexandria M
Koti, Madhuri
Dharsee, Moyez
Nuin, Paulo
Evans, Ken
Geraci, Joseph
Childs, Timothy
Chen, Jian
Li, Jieran
Weberpals, Johanne
Davey, Scott
Squire, Jeremy
Park, Paul C
Feilotter, Harriet
author_sort Haslehurst, Alexandria M
collection PubMed
description BACKGROUND: The epithelial to mesenchymal transition (EMT) is a molecular process through which an epithelial cell undergoes transdifferentiation into a mesenchymal phenotype. The role of EMT in embryogenesis is well-characterized and increasing evidence suggests that elements of the transition may be important in other processes, including metastasis and drug resistance in various different cancers. METHODS: Agilent 4 × 44 K whole human genome arrays and selected reaction monitoring mass spectrometry were used to investigate mRNA and protein expression in A2780 cisplatin sensitive and resistant cell lines. Invasion and migration were assessed using Boyden chamber assays. Gene knockdown of snail and slug was done using targeted siRNA. Clinical relevance of the EMT pathway was assessed in a cohort of primary ovarian tumours using data from Affymetrix GeneChip Human Genome U133 plus 2.0 arrays. RESULTS: Morphological and phenotypic hallmarks of EMT were identified in the chemoresistant cells. Subsequent gene expression profiling revealed upregulation of EMT-related transcription factors including snail, slug, twist2 and zeb2. Proteomic analysis demonstrated up regulation of Snail and Slug as well as the mesenchymal marker Vimentin, and down regulation of E-cadherin, an epithelial marker. By reducing expression of snail and slug, the mesenchymal phenotype was largely reversed and cells were resensitized to cisplatin. Finally, gene expression data from primary tumours mirrored the finding that an EMT-like pathway is activated in resistant tumours relative to sensitive tumours, suggesting that the involvement of this transition may not be limited to in vitro drug effects. CONCLUSIONS: This work strongly suggests that genes associated with EMT may play a significant role in cisplatin resistance in ovarian cancer, therefore potentially leading to the development of predictive biomarkers of drug response or novel therapeutic strategies for overcoming drug resistance.
format Online
Article
Text
id pubmed-3342883
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33428832012-05-04 EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer Haslehurst, Alexandria M Koti, Madhuri Dharsee, Moyez Nuin, Paulo Evans, Ken Geraci, Joseph Childs, Timothy Chen, Jian Li, Jieran Weberpals, Johanne Davey, Scott Squire, Jeremy Park, Paul C Feilotter, Harriet BMC Cancer Research Article BACKGROUND: The epithelial to mesenchymal transition (EMT) is a molecular process through which an epithelial cell undergoes transdifferentiation into a mesenchymal phenotype. The role of EMT in embryogenesis is well-characterized and increasing evidence suggests that elements of the transition may be important in other processes, including metastasis and drug resistance in various different cancers. METHODS: Agilent 4 × 44 K whole human genome arrays and selected reaction monitoring mass spectrometry were used to investigate mRNA and protein expression in A2780 cisplatin sensitive and resistant cell lines. Invasion and migration were assessed using Boyden chamber assays. Gene knockdown of snail and slug was done using targeted siRNA. Clinical relevance of the EMT pathway was assessed in a cohort of primary ovarian tumours using data from Affymetrix GeneChip Human Genome U133 plus 2.0 arrays. RESULTS: Morphological and phenotypic hallmarks of EMT were identified in the chemoresistant cells. Subsequent gene expression profiling revealed upregulation of EMT-related transcription factors including snail, slug, twist2 and zeb2. Proteomic analysis demonstrated up regulation of Snail and Slug as well as the mesenchymal marker Vimentin, and down regulation of E-cadherin, an epithelial marker. By reducing expression of snail and slug, the mesenchymal phenotype was largely reversed and cells were resensitized to cisplatin. Finally, gene expression data from primary tumours mirrored the finding that an EMT-like pathway is activated in resistant tumours relative to sensitive tumours, suggesting that the involvement of this transition may not be limited to in vitro drug effects. CONCLUSIONS: This work strongly suggests that genes associated with EMT may play a significant role in cisplatin resistance in ovarian cancer, therefore potentially leading to the development of predictive biomarkers of drug response or novel therapeutic strategies for overcoming drug resistance. BioMed Central 2012-03-19 /pmc/articles/PMC3342883/ /pubmed/22429801 http://dx.doi.org/10.1186/1471-2407-12-91 Text en Copyright ©2012 Haslehurst et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Haslehurst, Alexandria M
Koti, Madhuri
Dharsee, Moyez
Nuin, Paulo
Evans, Ken
Geraci, Joseph
Childs, Timothy
Chen, Jian
Li, Jieran
Weberpals, Johanne
Davey, Scott
Squire, Jeremy
Park, Paul C
Feilotter, Harriet
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
title EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
title_full EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
title_fullStr EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
title_full_unstemmed EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
title_short EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
title_sort emt transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342883/
https://www.ncbi.nlm.nih.gov/pubmed/22429801
http://dx.doi.org/10.1186/1471-2407-12-91
work_keys_str_mv AT haslehurstalexandriam emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT kotimadhuri emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT dharseemoyez emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT nuinpaulo emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT evansken emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT geracijoseph emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT childstimothy emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT chenjian emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT lijieran emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT weberpalsjohanne emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT daveyscott emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT squirejeremy emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT parkpaulc emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer
AT feilotterharriet emttranscriptionfactorssnailandslugdirectlycontributetocisplatinresistanceinovariancancer